Overview of the risk factors, prevention and management of SARS-COV-2
This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2020.
| Autor principal: | Mustafa, Nashrah |
|---|---|
| Outros Autores: | Hossain, Mahboob |
| Formato: | Tese |
| Idioma: | en_US |
| Publicado em: |
Brac University
2021
|
| Assuntos: | |
| Acesso em linha: | http://hdl.handle.net/10361/14501 |
Registros relacionados
-
In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
por: Iva, Yesmine Akter
Publicado em: (2022) -
Detection of genetic diversity of SARS-CoV-2 in wastewater to monitor COVID-19 transmission
por: Sarwar, Subyeta Binte
Publicado em: (2024) -
An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
por: Intesar, Mohammad Nafees
Publicado em: (2023) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
por: Bosu, Sagar
Publicado em: (2023) -
Wave-wise comparison of COVID 19 based on SARS-CoV-2 Variants of Concern (VOCs) in Bangladesh, India, Sri Lanka, Pakistan, Nepal and the probable reasons behind the less devastating effects of Delta variant in Bangladesh: a review
por: Hasan, Mahfuzul, et al.
Publicado em: (2022)